Tradition Wealth Management, LLC Tg Therapeutics, Inc. Transaction History

Tradition Wealth Management, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	SELL	$15.48 - $35.0 $35,371 - $79,975	-2,285 Reduced 27.72%	5,958 $148,000
Q1 2023 May 11, 2023	BUY	$10.23 - $19.34 $18,260 - $34,521	1,785 Added 27.64%	8,243 $124,000
Q2 2022 Aug 02, 2022	SELL	$3.74 - $10.66 $1,641 - $4,679	-439 Reduced 6.37%	6,458 $27,000
Q1 2022 May 11, 2022	BUY	$7.81 - $20.45 $6,412 - $16,789	821 Added 13.51%	6,897 $66,000
Q4 2021 Feb 14, 2022	BUY	$15.2 - $35.51 $17,176 - $40,126	1,130 Added 22.85%	6,076 $115,000
Q3 2021 Nov 12, 2021	BUY	$21.78 - $40.45 $8,929 - $16,584	410 Added 9.04%	4,946 $165,000
Q4 2020 Feb 16, 2021	BUY	$25.27 - $54.9 $114,624 - $249,026	4,536 New	4,536 $236,000

345

87.6M

2.35M

1.7M

Ticker TGTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 145,274,000
Market Cap $4.86B
Description
TG Therapeutics, Inc., a commercial stage biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its therapeutic product candidates include Ublituximab, an investigational glycoengineered monoclonal antibody for the treatment of B-cell non-hod...

Get notified when there are updates to the investment portfolio of Tradition Wealth Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Tradition Wealth Management, LLC with notifications on news.